首頁 > 市場調查報告書 > 製藥

消化器

市場調查報告書

商品編碼

1532645

胃腸道診斷市場 - 按測試類型、技術、應用、最終用途和全球預測

Gastrointestinal Diagnostics Market - By Test Type, Technology, Application, End-use & Global Forecast

出版日期: 2024年05月31日 | 出版商:

Global Market Insights Inc. | 英文 120 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

在創新設備推出激增的推動下，2024 年至 2032 年間，全球胃腸道診斷市場複合年成長率將達到 4.6a%。診斷技術的最新進展正在提高胃腸道評估的準確性、速度和舒適度。新設備，如先進的內視鏡、膠囊內視鏡和非侵入性影像工具，提供了改進的可視化和診斷功能，能夠更早、更精確地檢測胃腸道疾病。

這些創新對於治療大腸直腸癌、克隆氏症和腸躁症等複雜疾病至關重要。例如，2024 年 5 月，診斷和治療醫療技術領域的領先公司 Laborie Medical Technologies Corp. 推出了太陽能緊湊型系統和太陽能肛門直腸測壓導管，這是首款一次性 HRAM 導管。

人們對胃腸道健康意識的增強和對個人化醫療的需求也推動了創新診斷工具的興起。提高診斷準確性有助於制定治療計劃、改善患者治療效果並降低醫療成本。隨著製造商不斷開發和推出尖端設備，在對先進、高效和患者友好的診斷解決方案的需求的推動下，胃腸道診斷市場預計將進一步擴大。

胃腸道診斷行業的整體價值根據測試類型、技術、應用、最終用途和地區進行分類。

根據測試類型，血液檢測領域的胃腸道診斷市場收入從2024 年到2032 年將實現令人稱道的複合年成長率。提供非侵入性、準確的方法。這些測試利用生物標記和遺傳指標來提供早期診斷和監測疾病進展。血液檢測的便利性和減少的患者不適感推動了血液檢測的日益普及。此外，對預防性醫療保健和早期檢測的重視正在推動市場擴張。隨著研究不斷提高血液檢測的功效和範圍，其在胃腸道診斷中的作用預計將進一步提振市場需求。

在技術方面，ELISA 領域將在2024 年至2032 年出現顯著成長。和癌症）相關的生物標記。它提供準確定量結果的能力使其在臨床和研究環境中具有無價的價值。胃腸道疾病的盛行率不斷增加以及對可靠診斷工具的需求正在推動對基於 ELISA 的檢測的需求。隨著技術的進步和更多生物標記的發現，ELISA 在胃腸道診斷中的作用預計將擴大，進一步推動市場成長。

歐洲胃腸道診斷市場從2024年到2032年將呈現顯著的複合年成長率。，以提高胃腸道疾病檢測和管理的準確性和效率。該地區對早期診斷和個人化醫療的關注進一步刺激了需求。此外，嚴格的監管標準和研發投資支持創新診斷解決方案的成長。隨著歐洲繼續優先考慮胃腸道健康和先進診斷，預計該市場將持續強勁成長。

產業生態系統分析
產業影響力
- 成長動力
  - 胃腸道疾病盛行率增加
  - 擴大採用非侵入性測試
  - 人們對胃腸道健康的認知不斷提高
  - 診斷技術的技術進步
- 產業陷阱與挑戰
  - 診斷程序成本高
  - 有限的報銷政策
成長潛力分析
監管環境
技術景觀
波特的分析
PESTEL分析
未來市場趨勢

第 4 章：競爭格局

介紹
公司市佔率分析
公司矩陣分析
主要市場參與者的競爭分析
競爭定位矩陣
戰略儀表板

第 5 章：市場估計與預測：按測試類型，2021 - 2032 年

主要趨勢
內視鏡檢查
驗血
免疫球蛋白A測試
幽門螺旋桿菌檢測
鈣衛蛋白測試
其他測試類型

第 6 章：市場估計與預測：按技術分類，2021 - 2032 年

主要趨勢
培養和敏感度測試
酵素連結免疫吸附試驗
聚合酶鍊式反應
影像技術
快速診斷測試
其他技術

第 7 章：市場估計與預測：按應用分類，2021 - 2032

主要趨勢
感染
胃腸癌
發炎性腸道疾病
胃食道逆流症（GERD）
其他應用

第 8 章：市場估計與預測：按最終用途，2021 - 2032 年

主要趨勢
醫院
診斷實驗室
其他最終用戶

第 9 章：市場估計與預測：按地區分類，2021 - 2032 年

主要趨勢
北美洲
- 美國
- 加拿大
歐洲
- 德國
- 英國
- 法國
- 西班牙
- 義大利
- 荷蘭
- 歐洲其他地區
亞太地區
- 中國
- 日本
- 印度
- 澳洲
- 韓國
- 亞太地區其他地區
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 拉丁美洲其他地區
中東和非洲
- 南非
- 沙烏地阿拉伯
- 阿拉伯聯合大公國
- 中東和非洲其他地區

第 10 章：公司簡介

Abbott Laboratories
Beckman Coulter, Inc.
Becton, Dickinson and Company
bioMerieux
Bio-Rad Laboratories, Inc.
DiaSorin S.p.A
EKF Diagnostics Holdings plc
F. Hoffmann-La Roche Ltd
Fujifilm Holdings Corporation
Meridian Bioscience
QIAGEN N.V.
R-Biopharm AG
Siemens Healthineers AG
Sysmex Corporation
Thermo Fisher Scientific Inc.

簡介目錄

Product Code: 9711

Global Gastrointestinal Diagnostics Market will witness 4.6a% CAGR between 2024 and 2032, driven by the surge in innovative device launches. Recent advancements in diagnostic technology are enhancing the accuracy, speed, and comfort of gastrointestinal assessments. New devices, such as advanced endoscopes, capsule endoscopes, and non-invasive imaging tools, offer improved visualization and diagnostic capabilities, enabling earlier and more precise detection of gastrointestinal conditions.

These innovations are crucial for managing complex disorders like colorectal cancer, Crohn's disease, and irritable bowel syndrome. For instance, in May 2024, Laborie Medical Technologies Corp., a leading company in diagnostic and therapeutic medical technology, launched the Solar Compact System and the Solar Anorectal Manometry Catheter, which first disposable HRAM catheter available.

The rise in innovative diagnostic tools is also fueled by increasing awareness of gastrointestinal health and the demand for personalized medicine. Enhanced diagnostic accuracy helps in tailoring treatment plans, improving patient outcomes, and reducing healthcare costs. As manufacturers continue to develop and introduce cutting-edge devices, the gastrointestinal diagnostics market is expected to expand further, driven by the need for advanced, efficient, and patient-friendly diagnostic solutions.

The overall Gastrointestinal Diagnostics Industry value is classified based on the test type, technology, application, end-use, and region.

Based on test type, the gastrointestinal diagnostics market revenue from the blood test segment will register a commendable CAGR from 2024 to 2032. Innovative blood-based diagnostic assays are offering non-invasive, accurate methods for detecting gastrointestinal disorders, such as colorectal cancer and inflammatory bowel disease. These tests utilize biomarkers and genetic indicators to provide early diagnosis and monitor disease progression. The convenience and reduced patient discomfort associated with blood tests drive their growing popularity. Additionally, the emphasis on preventive healthcare and early detection is fueling market expansion. As research continues to enhance the efficacy and range of blood tests, their role in gastrointestinal diagnostics is expected to further boost market demand.

In terms of technology, the ELISA segment will witness an appreciable growth from 2024 to 2032. ELISA offers a highly sensitive and specific method for detecting biomarkers related to various gastrointestinal conditions, including infections, inflammatory diseases, and cancers. Its ability to provide accurate quantitative results makes it invaluable in both clinical and research settings. The increasing prevalence of gastrointestinal disorders and the need for reliable diagnostic tools are driving the demand for ELISA-based tests. As technology advances and more biomarkers are identified, the role of ELISA in gastrointestinal diagnostics is expected to expand, further fueling market growth.

Europe gastrointestinal diagnostics market will exhibit a notable CAGR from 2024 to 2032. European healthcare providers are increasingly adopting advanced diagnostic tools, such as endoscopes, imaging devices, and biomarker tests, to enhance the accuracy and efficiency of gastrointestinal disease detection and management. The region's focus on early diagnosis and personalized medicine further fuels demand. Additionally, stringent regulatory standards and investments in research and development support the growth of innovative diagnostic solutions. As Europe continues to prioritize gastrointestinal health and advanced diagnostics, the market is expected to see continued robust growth.

Chapter 1 Methodology & Scope

1.1 Market scope & definitions
1.2 Research design
- 1.2.1 Research approach
- 1.2.2 Data collection methods
1.3 Base estimates & calculations
- 1.3.1 Base year calculation
- 1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
- 1.5.1 Primary sources
- 1.5.2 Data mining sources

Chapter 2 Executive Summary

2.1 Industry 360° synopsis

Chapter 3 Industry Insights

3.1 Industry ecosystem analysis
3.2 Industry impact forces
- 3.2.1 Growth drivers
  - 3.2.1.1 Increasing prevalence of gastrointestinal diseases
  - 3.2.1.2 Growing adoption of non-invasive tests
  - 3.2.1.3 Rising awareness about gastrointestinal health
  - 3.2.1.4 Technological advancements in diagnostic technologies
- 3.2.2 Industry pitfalls & challenges
  - 3.2.2.1 High cost of diagnostic procedures
  - 3.2.2.2 Limited reimbursement policies
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Technological landscape
3.6 Porter's analysis
3.7 PESTEL analysis
3.8 Future market trends

Chapter 4 Competitive Landscape, 2023

4.1 Introduction
4.2 Company market share analysis
4.3 Company matrix analysis
4.4 Competitive analysis of major market players
4.5 Competitive positioning matrix
4.6 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Test Type, 2021 - 2032 ($ Mn)

5.1 Key trends
5.2 Endoscopy
5.3 Blood test
5.4 Immunoglobulin A test
5.5 H. pylori test
5.6 Calprotectin test
5.7 Other test types

Chapter 6 Market Estimates and Forecast, By Technology, 2021 - 2032 ($ Mn)

6.1 Key trends
6.2 Culture and sensitivity testing
6.3 ELISA
6.4 PCR
6.5 Imaging technologies
6.6 Rapid diagnostic tests
6.7 Other technologies

Chapter 7 Market Estimates and Forecast, By Application, 2021 - 2032 ($ Mn)

7.1 Key trends
7.2 Infection
7.3 Gastrointestinal cancer
7.4 Inflammatory bowel disease
7.5 Gastroesophageal reflux disease (GERD)
7.6 Other applications

Chapter 8 Market Estimates and Forecast, By End-Use, 2021 - 2032 ($ Mn)

8.1 Key trends
8.2 Hospitals
8.3 Diagnostic laboratories
8.4 Other end-users

Chapter 9 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

9.1 Key trends
9.2 North America
- 9.2.1 U.S.
- 9.2.2 Canada
9.3 Europe
- 9.3.1 Germany
- 9.3.2 UK
- 9.3.3 France
- 9.3.4 Spain
- 9.3.5 Italy
- 9.3.6 Netherlands
- 9.3.7 Rest of Europe
9.4 Asia Pacific
- 9.4.1 China
- 9.4.2 Japan
- 9.4.3 India
- 9.4.4 Australia
- 9.4.5 South Korea
- 9.4.6 Rest of Asia Pacific
9.5 Latin America
- 9.5.1 Brazil
- 9.5.2 Mexico
- 9.5.3 Argentina
- 9.5.4 Rest of Latin America
9.6 Middle East and Africa
- 9.6.1 South Africa
- 9.6.2 Saudi Arabia
- 9.6.3 UAE
- 9.6.4 Rest of Middle East and Africa